2
Views
0
CrossRef citations to date
0
Altmetric
Correspondence

Re: Quantitative evaluation of AgNORs in bone tumours

, &
Page 98 | Published online: 06 Jul 2009

References

  • Tuccari G, Ofner D, Rfischoff J. Re: Quantitative evaluation of AgNORs in bone tumours. Pathology 2003; 35: 455 [Letter].
  • Arora B, Jindal K, Kumar S, Rekhi B, Arora H, Arora DR. Quantitative evaluation of AgNORs in bone tumours. Pathology 2003; 35: 106–8.
  • Bancroft DJ. Cytoplasmic granules, organelles and neuroendocrine. In: Bancroft JD, Gamble JD, editors. Theory and Practice of Histological Techniques. 5th ed. London: Churchill Livingstone, 2002; 350–1.
  • Egan MJ, Crocker J. Nucleolar organiser regions in pathology. Br J Cancer 1992; 65: 1–7.
  • Papadhimitriou SI, Daskalopopoulau D, Tsaftaridis P, Markidou S, Stamatelon M. Evaluation of argyrophilic nucleolar organiser regions (AgNORs) in multiple myeloma. J Clin Pathol 2000; 53: 462–5.
  • Clohisy JC, Schajowicz F, Vaziri DM, et al. Assessment of arygyrophilic nucleolar organizer region quantification in benign and malignant bone tumours. Clin Orthop 1995; 310: 29–36.
  • Schwint AE, Araujo ES, Cole A, Itoiz ME, Cabrini RL. Nucleolar organizer regions in parosteal and central osteosacromas. Clin Orthop 1996; 327: 253–8.
  • Crocker J, Egan Mi. Correlation between NOR sizes and numbers in Non-Hodgkin's lymphomas. J Pathol 1988; 156: 233–9.
  • Ofner D, Riedmann B, Maier H, et al. Standardized staining and analysis of argyrophilic nucleolar organizer region associated proteins (AgNORs) in radically resected colorectal adenocarcinoma—correla-tion with tumour stage and longterm survival. J Pathol 1995; 175: 441–8.
  • Arora B, Jeevan D, Punia RS, Kumar S, Arora DR. AgNORs in squamous cell carcinoma of head and neck. JIMA 2002; 100 (5): 314–6.
  • Arora B, Jain R, Kumar S, Rekhi B, Arora H, Arora DR. Morphometric analysis of AgNORs in lymph node lesions. Adv Clin Pathol 2002; 6: 95–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.